Trademark: 97099723
Status Date
Monday, December 18, 2023
Filing Date
Friday, October 29, 2021
Published for Opposition
Tuesday, March 21, 2023
Abandoned Date
Monday, December 18, 2023
42 Development of new treatments in the nature of development for biopharmaceuticals for the treatment of pathologies related to vascular disease; research and development of pharmaceutical preparations and medicines; medical and scientific research services in the fields of inflammation, immuno-inflammatory, chronic diseases such as rheumatoid arthritis (RA), psoriasis, inflammatory bowel disease (IBD), multiple sclerosis (MS), and atherosclerosis, cardio vascular medicine, angiogenesis, vascular disruptive, cancer treatment and diagnosis; medical and scientific research, namely, conducting clinical trials for others; medical research; pharmaceutical drug development services; biopharmaceutical product evaluation; biopharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of three curved lines.
Dec 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 18, 2023
Abandonment - No Use Statement Filed
May 16, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 21, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 21, 2023
Published For Opposition
Mar 1, 2023
Notification Of Notice Of Publication E-Mailed
Feb 15, 2023
Approved For Pub - Principal Register
Feb 14, 2023
Examiner's Amendment Entered
Feb 14, 2023
Notification Of Examiners Amendment E-Mailed
Feb 14, 2023
Examiners Amendment E-Mailed
Feb 14, 2023
Examiners Amendment -Written
Aug 15, 2022
Notification Of Non-Final Action E-Mailed
Aug 15, 2022
Non-Final Action E-Mailed
Aug 15, 2022
Non-Final Action Written
Aug 8, 2022
Assigned To Examiner
Nov 11, 2021
Notice Of Design Search Code E-Mailed
Nov 10, 2021
New Application Office Supplied Data Entered
Nov 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
